NYSE:EWMedical Equipment
Is Edwards Lifesciences (EW) Below Fair Value Following New York Valves Trial Data?
Edwards Lifesciences (EW) has drawn fresh attention after unveiling extensive clinical data at the New York Valves 2026 conference. The company highlighted results from the PROGRESS, EARLY TAVR and PARTNER 3 trials on its SAPIEN platform.
See our latest analysis for Edwards Lifesciences.
Alongside the New York Valves data, Edwards Lifesciences has attracted fresh attention from its index reclassification, with recent additions to several Russell value and defensive indices coinciding with a...